Oxford BioMedica ( (GB:OXB) ) has provided an announcement.
Oxford BioMedica PLC has announced a change in its voting rights, with Briarwood Chase Management LLC increasing its stake to 11.03% from a previous 10.54%. This acquisition of voting rights signifies a significant shift in shareholder influence, potentially impacting the company’s strategic decisions and stakeholder interests.
More about Oxford BioMedica
Oxford BioMedica PLC is a UK-based company operating in the biotechnology industry, primarily involved in the development and commercialization of gene and cell therapy products. The company focuses on innovative treatments for various diseases, leveraging its expertise in viral vector technology to serve the healthcare market.
YTD Price Performance: -25.19%
Average Trading Volume: 17,789
Technical Sentiment Signal: Buy
Current Market Cap: $428.3M
For detailed information about OXB stock, go to TipRanks’ Stock Analysis page.